Jun 8, 2019
- Presented as a late-breaker at the American Diabetes Association (ADA) 79th Scientific Sessions, new real-world data demonstrate that monitoring glucose with FreeStyle Libre System has a positive impact among adults with Type 2 Diabetes who use multiple injections of insulin daily
- Findings represent the first ever evaluation of real-world evidence specifically from the subset of people with Type 2 diabetes using Abbott's FreeStyle Libre system
- Data underscore how actionable insights from the FreeStyle Libre system could help the more than 425 million people with diabetes1 globally make better decisions to improve diabetes management